ClinicalTrials.govpublic full text
Reduced-Intensity Conditioning (RIC) and Myeloablative Conditioning (MAC) for HSCT in AML/MDS
acute myeloid leukemia (aml), myelodysplastic syndrome (mds), hematopoietic stem cell transplant (hsct), interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 865205
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.